• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左旋多巴反应性-全身性肌张力障碍发作和呻吟在 DNAJC6 相关的青少年帕金森病中。

Levodopa responsive-generalized dystonic spells and moaning in DNAJC6 related Juvenile Parkinson's disease.

机构信息

Movement Disorders, Neurological Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.

出版信息

Parkinsonism Relat Disord. 2020 Dec;81:188-189. doi: 10.1016/j.parkreldis.2020.10.046. Epub 2020 Nov 5.

DOI:10.1016/j.parkreldis.2020.10.046
PMID:33181391
Abstract

This is a case of young man who has severe generalized dystonic spells with moaning with severe parkinsonism, which improves with dopaminergic medications. Patient was found to be DNAJC6 related juvenile Parkinson's disease. This case adds to the phenotypic variability of the DNAJC6 juvenile Parkinson's disease as severe dystonic spells and moaning has not been reported previously. Early diagnosis and symptomatic treatment with dopaminergic medications helps significantly to improve the quality of life.

摘要

这是一个患有严重全身性肌张力障碍发作伴呻吟的年轻男性病例,伴有严重帕金森病,对多巴胺能药物治疗有效。患者被发现与 DNAJC6 相关的青少年帕金森病有关。该病例增加了 DNAJC6 青少年帕金森病的表型变异性,因为以前没有报道过严重的肌张力障碍发作和呻吟。早期诊断和多巴胺能药物的对症治疗有助于显著提高生活质量。

相似文献

1
Levodopa responsive-generalized dystonic spells and moaning in DNAJC6 related Juvenile Parkinson's disease.左旋多巴反应性-全身性肌张力障碍发作和呻吟在 DNAJC6 相关的青少年帕金森病中。
Parkinsonism Relat Disord. 2020 Dec;81:188-189. doi: 10.1016/j.parkreldis.2020.10.046. Epub 2020 Nov 5.
2
DNAJC6 mutation causing cranial-onset dystonia with tremor dominant levodopa non-responsive parkinsonism: A novel phenotype.DNAJC6 突变导致以头部起病的震颤为主的左旋多巴反应性帕金森病:一种新的表型。
Parkinsonism Relat Disord. 2021 Aug;89:1-3. doi: 10.1016/j.parkreldis.2021.06.013. Epub 2021 Jun 23.
3
DNAJC6 Mutations Disrupt Dopamine Homeostasis in Juvenile Parkinsonism-Dystonia.DNAJC6 突变破坏青少年帕金森病-肌张力障碍中的多巴胺稳态。
Mov Disord. 2020 Aug;35(8):1357-1368. doi: 10.1002/mds.28063. Epub 2020 May 30.
4
DNAJC6 Mutations Associated With Early-Onset Parkinson's Disease.DNAJC6 突变与早发性帕金森病相关。
Ann Neurol. 2016 Feb;79(2):244-56. doi: 10.1002/ana.24553. Epub 2016 Jan 14.
5
DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability.DNAJC6 负责具有表型可变性的青少年帕金森病。
Parkinsonism Relat Disord. 2013 Mar;19(3):320-4. doi: 10.1016/j.parkreldis.2012.11.006. Epub 2012 Dec 2.
6
Haplotype Analysis on the Relationship of the DNAJC6 Gene with Early-Onset Parkinson's Disease Risk in a Chinese Population.单体型分析 DNAJC6 基因与中国人群早发性帕金森病风险的关系。
J Parkinsons Dis. 2019;9(1):109-120. doi: 10.3233/JPD-181411.
7
Continuous levodopa infusions to treat complex dystonia in Parkinson's disease.持续左旋多巴输注治疗帕金森病复杂肌张力障碍。
Neurology. 1989 Jul;39(7):888-91. doi: 10.1212/wnl.39.7.888.
8
DNAJC6 mutations are not common causes of early onset Parkinson's disease in Chinese Han population.在中国汉族人群中,DNAJC6突变并非早发性帕金森病的常见病因。
Neurosci Lett. 2016 Nov 10;634:60-62. doi: 10.1016/j.neulet.2016.09.044. Epub 2016 Sep 26.
9
Dopa responsive dystonia and juvenile Parkinson's disease: two subtypes of the same disorder?多巴反应性肌张力障碍与青少年帕金森病:同一疾病的两种亚型?
Acta Neurol (Napoli). 1992 Aug-Dec;14(4-6):451-4.
10
Dystonia in Parkinson's disease: clinical and pharmacological features.帕金森病中的肌张力障碍:临床和药理学特征
Ann Neurol. 1988 Jan;23(1):73-8. doi: 10.1002/ana.410230112.

引用本文的文献

1
Dysfunction of synaptic endocytic trafficking in Parkinson's disease.帕金森病中突触内吞运输功能障碍。
Neural Regen Res. 2024 Dec 1;19(12):2649-2660. doi: 10.4103/NRR.NRR-D-23-01624. Epub 2024 Mar 1.
2
Sleep disorders cause Parkinson's disease or the reverse is true: Good GABA good night.睡眠障碍导致帕金森病还是相反:良好的 GABA 带来美好的夜晚。
CNS Neurosci Ther. 2024 Mar;30(3):e14521. doi: 10.1111/cns.14521.
3
Modulating Stress Proteins in Response to Therapeutic Interventions for Parkinson's Disease.调节应激蛋白以应对帕金森病的治疗干预。
Int J Mol Sci. 2023 Nov 12;24(22):16233. doi: 10.3390/ijms242216233.
4
Genetic Evidence for Endolysosomal Dysfunction in Parkinson's Disease: A Critical Overview.遗传证据表明帕金森病中内溶酶体功能障碍:批判性综述。
Int J Mol Sci. 2023 Mar 28;24(7):6338. doi: 10.3390/ijms24076338.
5
A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson's disease: beneficial or detrimental effects.非甾体抗炎药(NSAIDs)对帕金森病潜在影响的故事:有益还是有害作用。
Inflammopharmacology. 2023 Apr;31(2):673-688. doi: 10.1007/s10787-023-01192-2. Epub 2023 Mar 24.
6
Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson's disease.多巴胺转运体和突触囊泡分选缺陷是辅助蛋白相关帕金森病的基础。
Cell Rep. 2023 Mar 28;42(3):112231. doi: 10.1016/j.celrep.2023.112231. Epub 2023 Mar 14.